CareFusion UK 244 Ltd

Reigate Place, 43 London Road , Reigate, Surrey, RH2 9PW
Telephone: +44 1737 237 940
Fax: +44 1737 237 950
E-mail: enquiries@chloraprep.com
WWW: http://www.chloraprep.co.uk
Medical Information e-mail: enquiries@chloraprep.co.uk
Customer Care direct line: 0800 043 7546
Customer Care direct line: +44 1737 237 940


Summary of Product Characteristics last updated on the eMC: 16/01/2012
SPC ChloraPrep


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

ChloraPrep 2% chlorhexidine gluconate w/v / 70% isopropyl alcohol v/v cutaneous solution


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Chlorhexidine gluconate 2.0% w/v

Isopropyl alcohol 70% v/v

For excipients see 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Cutaneous Solution.

The solution appears as a clear liquid having an odour of alcohol.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

The medicinal product is to be used for disinfection of the skin prior to invasive procedures.


Go to top of the page
4.2 Posology and method of administration

For cutaneous use.

One applicator is used containing 0.67 ml, 1.5 ml, 3 ml, 10.5 ml or 26 ml of the ChloraPrep alcoholic solution.

The choice of applicator will depend on the invasive procedure being undertaken and the clinician's preference.

Applicator

Coverage Area (cm x cm)

For Procedures such as:

0.67 ml (Sepp)

 

5 x 8

- Peripheral cannulation

- Simple biopsy

- Routine venipuncture

1.5 ml

1.5 ml (Frepp)

10 x 13

- Blood culture collection

- Peripheral cannulation

- Peripheral arterial line cannulation

- Simple biopsy

- Routine venipuncture

- Dialysis Fistula/Graft site cleansing

3 ml

15 x 15

- Midline & Central Venous Catheter (CVC) insertion and maintenance

- Peritoneal dialysis site cleansing

10.5 ml

 

26 ml

25 x 30

 

 

 

 

50 x 50

- Minor and major surgical procedures

- Implantable device placement

- Prosthetic device placement or removal

- Midline, Peripheral Intravascular Central Catheter (PICC) & CVC insertion and maintenance

- Cardiac catheterisation and Cardiac Cath Lab procedures

- Interventional Radiology procedure

The applicator is removed from the wrapper and held with the sponge facing downward. The applicator is squeezed gently to break the ampoule containing the antiseptic solution, which is released onto the sponge in a controlled flow (for the 0.67 ml the barrel is squeezed; for the 26 ml applicator the lever is pressed).

The broken ampoule remains safely contained within the applicator. The sponge is gently pressed against the patient's skin in order to apply the antiseptic solution. A back and forth action of the sponge should be used for 30 seconds. The 26 ml applicator includes two swabs. Clean umbilicus with enclosed swabs when applicable. (Moisten swabs by pressing against solution-soaked sponge applicator.) The area covered should be allowed to dry naturally.


Go to top of the page
4.3 Contraindications

The medicinal product is contra-indicated where patients have shown previous hypersensitivity to chlorhexidine or isopropyl alcohol.


Go to top of the page
4.4 Special warnings and precautions for use

The solution is an irritant to eyes and mucous membranes. It should therefore be kept away from these areas. If the solution comes in contact with the eyes, they should be washed promptly and thoroughly with water.

It should also not be used on open skin wounds, broken or damaged skin, for lumbar puncture or in children less than 2 months of age. In addition, contact with the brain, meninges and middle ear must be avoided.

Prolonged skin contact with alcoholic solutions should be avoided.

Rarely allergic or irritation skin reactions have been reported with chlorhexidine.

For external use only.

Do not use with electrocautery procedures until dry. Remove any soaked materials, drapes or gowns before proceeding.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Alcohol should not be brought into contact with some vaccines and skin test injections (patch tests). If in doubt, consult the vaccine manufacturers' literature.


Go to top of the page
4.6 Pregnancy and lactation

There are no studies with this product in pregnant or lactating women. However as percutaneous absorption is negligible, there is no reason why this product may not be used during pregnancy or by breast feeding mothers.


Go to top of the page
4.7 Effects on ability to drive and use machines

No effects are reported.


Go to top of the page
4.8 Undesirable effects

Rarely allergic or irritation skin reactions have been reported with chlorhexidine and isopropyl alcohol.


Go to top of the page
4.9 Overdose

There are no reports of this occurring and the nature of the product makes it unlikely.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

ATC code D08A C52 (Chlorhexidine, combinations).

Mode of Action: Bisbiguanide antiseptics exert their lethal effect upon bacterial cells through non-specific interaction with acidic phospholipids of the cell membranes.

Since there is little percutaneous absorption of isopropyl alcohol or chlorhexidine gluconate and the medicinal product is indicated for use on pre-injection sites, pharmacodynamic studies have not been undertaken.


Go to top of the page
5.2 Pharmacokinetic properties

There is little absorption of isopropyl alcohol or of chlorhexidine gluconate through intact skin. Pharmacokinetic studies have not been conducted with the product.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber that are not already included elsewhere in the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Purified water.


Go to top of the page
6.2 Incompatibilities

Chlorhexidine is incompatible with soap and other anionic agents


Go to top of the page
6.3 Shelf life

24 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.

Avoid freezing.

Store in the original packaging


Go to top of the page
6.5 Nature and contents of container

The alcoholic solution is contained in a borosilicate Type 1 glass ampoule which is housed in an applicator.

The applicator consists of a HDPE plastic handle/barrel containing the ampoule with the ChloraPrep solution. For the 1.5 ml (both the Frepp® and standard applicator) and 3 ml, 10.5 ml and 26 ml applicators, the handle is bonded to a Novonette film and a polyester urethane foam. For the 0.67 ml Sepp® applicator, the barrel is bonded to the polyester urethane foam which is stitch-bonded to a polyester airweave.

The applicator is wrapped in an ethyl vinyl acetate film.

The medicinal product is available as 0.67 ml, 1.5 ml, 3 ml, 10.5 ml and 26 ml fill volumes.

Pack Size:

 

0.67 ml (Sepp®):

200 applicators

1.5ml (Frepp®):

20 applicators

1.5 ml and 3 ml:

25 applicators

10.5 ml:

1 applicator or 25 applicators

26 ml:

1 applicator


Go to top of the page
6.6 Special precautions for disposal and other handling

The solution is flammable. Do not use while smoking, or near any naked flames or strong heat source. Avoid exposure of the container and contents to naked flames during use, storage and disposal.

This product is for single use only.

Discard after use as per clinical waste procedures.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

CareFusion U.K. 244 Ltd.

43 London Road

Reigate

Surrey RH2 9 PW

(44) 1737-237-940


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 31760/0002


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

08/09/2005


Go to top of the page
10. DATE OF REVISION OF THE TEXT

19/07/10



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/22302/SPC/


Active Ingredients/Generics

 
   chlorhexidine gluconate
   isopropyl alcohol